IMM 2.94% 35.0¢ immutep limited

Poster Display session (ID 9) 171P - Biomarker and multivariate...

  1. 25,427 Posts.
    lightbulb Created with Sketch. 1379
    Poster Display session (ID 9)

    171P - Biomarker and multivariate analyses results from AIPAC: A phase IIb study comparing eftilagimod alpha (a soluble LAG-3 protein) vs. placebo in combination with weekly paclitaxel in HR+ HER2- metastatic breast cancer (ID 179)

    Presentation Number
    171P
    Lecture Time
    12:15 - 12:15
    Speakers
    Session Name
    Poster Display session (ID 9)
    Room
    Exhibition area
    Date
    Wed, 04.05.2022
    Time
    12:15 - 13:00

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
0.010(2.94%)
Mkt cap ! $501.1M
Open High Low Value Volume
34.0¢ 35.5¢ 34.0¢ $569.3K 1.637M

Buyers (Bids)

No. Vol. Price($)
19 201147 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 378267 41
View Market Depth
Last trade - 13.05pm 16/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.